Pressure Biosciences Valuation
| PBIODelisted Stock | USD 0.49 0.00 0.00% |
Pressure Biosciences is overvalued. Pressure Biosciences holds a recent Real Value of $0.47 per share. The prevailing price of the company is $0.49. Our model determines the value of Pressure Biosciences from analyzing the company fundamentals such as Return On Asset of -0.93, shares outstanding of 11.07 M, and Shares Owned By Institutions of 0.05 % as well as examining its technical indicators and probability of bankruptcy. . In general, most investors support obtaining undervalued entities and abandoning overvalued entities since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
Please note that Pressure Biosciences' price fluctuation is very steady at this time. Calculation of the real value of Pressure Biosciences is based on 3 months time horizon. Increasing Pressure Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Pressure otc stock is determined by what a typical buyer is willing to pay for full or partial control of Pressure Biosciences. Since Pressure Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Pressure OTC Stock. However, Pressure Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.49 | Real 0.47 | Hype 0.49 |
The intrinsic value of Pressure Biosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Pressure Biosciences' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Pressure Biosciences helps investors to forecast how Pressure otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Pressure Biosciences more accurately as focusing exclusively on Pressure Biosciences' fundamentals will not take into account other important factors: Pressure Biosciences Total Value Analysis
Pressure Biosciences is at this time forecasted to have valuation of 33.23 M with market capitalization of 23.22 M, debt of 150 K, and cash on hands of 121.57 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Pressure Biosciences fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
33.23 M | 23.22 M | 150 K | 121.57 K |
Pressure Biosciences Investor Information
The company recorded a loss per share of 2.59. Pressure Biosciences last dividend was issued on the 5th of June 2017. The entity had 1:30 split on the 5th of June 2017. Based on the key indicators related to Pressure Biosciences' liquidity, profitability, solvency, and operating efficiency, Pressure Biosciences is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Pressure Biosciences Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Pressure Biosciences has an asset utilization ratio of 70.69 percent. This suggests that the OTC Stock is making $0.71 for each dollar of assets. An increasing asset utilization means that Pressure Biosciences is more efficient with each dollar of assets it utilizes for everyday operations.Pressure Biosciences Ownership Allocation
The market capitalization of Pressure Biosciences is $23.22 Million. Roughly 98.68 pct. of Pressure Biosciences outstanding shares are held by general public with 1.27 % owned by insiders and only 0.05 (%) by third-party entities. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.Pressure Biosciences Profitability Analysis
The company reported the previous year's revenue of 2 M. Net Loss for the year was (20.15 M) with profit before overhead, payroll, taxes, and interest of 1.06 M.About Pressure Biosciences Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Pressure Biosciences. In general, an absolute valuation paradigm, as applied to this otc stock, attempts to find the value of Pressure Biosciences based exclusively on its fundamental and basic technical indicators. By analyzing Pressure Biosciences's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Pressure Biosciences's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Pressure Biosciences. We calculate exposure to Pressure Biosciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Pressure Biosciences's related companies.Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the North America, Europe, and Asia. As of August 2, 2022, Pressure BioSciences, Inc. operates as a subsidiary of Emergent Health Corp. Pressure Biosciences operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 12 people.
8 Steps to conduct Pressure Biosciences' Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Pressure Biosciences' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Pressure Biosciences' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Pressure Biosciences' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Pressure Biosciences' revenue streams: Identify Pressure Biosciences' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Pressure Biosciences' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Pressure Biosciences' growth potential: Evaluate Pressure Biosciences' management, business model, and growth potential.
- Determine Pressure Biosciences' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Pressure Biosciences' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Pressure Biosciences Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 9.1 M | |
| Retained Earnings | -118.3 M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Pressure OTC Stock
If you are still planning to invest in Pressure Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pressure Biosciences' history and understand the potential risks before investing.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |